14-05-2013

Evogene Ltd. (EVGN) announced its financial results for the first quarter ended March 31, 2013. Revenues for the first quarter of 2013 grew to $4.6 million, compared to $4.2 million for the same period in 2012. Evogene’s current revenues consist primarily of research and licensing revenues ...

more

Advanced Technological Solutions Ltd. selected as exclusive representative

29-11-2012

WITec, worldwide leader in nano-analytical microscopy systems, has appointed Advanced Technological Solutions Ltd. (ATSL) as its exclusive distributor in Israel. From now on ATSL will support WITec’s market entry and promote the full product line of high-resolution SNOM, AFM and Raman Imaging ...

more

24-10-2012

KSH Business Unit Performance Materials was appointed as distributor for Tagra’s range of encapsulated actives, oils and pigments. The products are developed and produced by applying Tagra’s manufacturing technology, RND™ (Release On Demand), which seals each micro-capped ingredient from ...

more

04-04-2012

Evogene Ltd. announced completion of an expansion program of its R&D facilities, resulting in a greater than 50% increase in the company's gene validation & plant growth capacity. The expansion was conducted in two stages: the first stage included reconstruction of new molecular and tissue ...

more

Wholly owned Subsidiary Expanding Castor Bean Activity in Brazil

04-01-2012

Evogene Ltd. announced that it is establishing Evofuel, a wholly owned subsidiary, to focus on developing seed for advanced second-generation feedstock for biofuel. Included in the activities that are being transferred from the parent company to Evofuel is the development and ...

more

Epigenomics expands commercial reach for CE-marked product beyond home market

18-10-2010

Epigenomics AG and Pronto Diagnostics Ltd. announced that they have signed an exclusive distributor agreement for the commercialization of Epigenomics’ Epi proColon test in Israel. Epi proColon is the world’s first CE-marked molecular diagnostic test for the early detection of colorectal ...

more

05-08-2010

Teva Pharmaceutical Industries Ltd. announced that the Company received approval from the European Commission to proceed with its acquisition of ratiopharm. In connection with this approval and following the Commission's review of this transaction, Teva made certain limited commitments, which ...

more

Protea has become a fully owned subsidiary of NasVax

14-07-2009

NasVax Ltd. announced that it has closed the purchase of 100% of the shares of Protea Vaccine Technologies of Kiryat Shmona Israel. As a result, Protea has become a fully owned subsidiary of NasVax. In June 2009, Protea announced that it signed a Research and License Option Agreement with ...

more

25-03-2009

Sun Pharmaceutical Industries Ltd. announced its subsidiary, Alkaloida Chemical Company Exclusive Group Ltd. (Alkaloida), has extended the Expiration Date of the Tender Offer for the purchase of all outstanding Ordinary Shares of Taro Pharmaceutical Industries Ltd. The Offer will now expire ...

more

01-12-2008

NasVax Ltd. announced that it has signed an agreement with Protea Vaccine Technologies Ltd (Protea) to purchase all of the company's shares. Protea is developing an innovative next-generation vaccine against diseases caused by Streptococcus pneumoniae, based on widely conserved ...

more